Back to WA Weiss Asset Management LP
ALXN
Showing 0 of 3 quarters
Position history for WAWeiss Asset Management LP's holdings in ALEXION PHARMACEUTICALS INC
As of its Q2 2021 13F, Weiss Asset Management held 274,142 shares of ALXN (Alexion Pharmaceuticals), worth $50.4M. Weiss Asset Management's 13F filings listed ALXN from Q1 2021 to Q2 2021, 2 quarterly filings. ALXN was 1.3% of Weiss Asset Management's reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
—
No position history available for this security.